XLV is trading 3.87% down at $162.44 after-hours; no verified earnings release, FDA action, or other XLV-specific announcement explains the decline.

  • XLV gained 0.35% during the September 21, 2026 regular session.
  • XLV went ex-dividend on September 21 for a $0.64223 distribution, insufficient by itself to explain the move.
  • The broader market was sharply higher; thin extended-hours liquidity or delayed sector news may be involved.